ResearcherLMU KlinikumActive in the last 2 years

Paul Rogowski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3351-8896; OpenAlex author ID A5072250420. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 11

Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

Improved PTV coverage and OAR sparing with stereotactic MRI-guided online adaptive radiotherapy with elective fields in pancreatic cancer. Last author DOI 10.1016/j.tipsro.2025.100354 ↗
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report. Co-author DOI 10.1159/000545975 ↗
Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. Last author DOI 10.1016/j.ctro.2024.100738 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Maximilian Niyazi · 3 shared papers, 2024–2025 · strength 0.61
Marlies Vornhülz · 2 shared papers, 2024–2025 · strength 0.41
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
- Paper Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. DOI 10.1016/j.ctro.2024.100738 ↗
Georg Beyer · 2 shared papers, 2024–2025 · strength 0.41
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
- Paper Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. DOI 10.1016/j.ctro.2024.100738 ↗
Christoph Benedikt Westphalen · 2 shared papers, 2024–2025 · strength 0.41
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
- Paper Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. DOI 10.1016/j.ctro.2024.100738 ↗
Mohamed A. Shouman · 2 shared papers, 2024–2025 · strength 0.41
- Paper Improved PTV coverage and OAR sparing with stereotactic MRI-guided online adaptive radiotherapy with elective fields in… DOI 10.1016/j.tipsro.2025.100354 ↗
- Paper Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. DOI 10.1016/j.ctro.2024.100738 ↗
Simon Sirtl · 1 shared paper, 2025 · strength 0.21
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
Kathrin Heinrich · 1 shared paper, 2025 · strength 0.21
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
Volker Heinemann · 1 shared paper, 2025 · strength 0.21
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
Alexander Kleger · 1 shared paper, 2025 · strength 0.21
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
Julia V. Mayerle · 1 shared paper, 2025 · strength 0.21
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975 ↗
Dinah Konnerth · 1 shared paper, 2025 · strength 0.20
- Paper Improved PTV coverage and OAR sparing with stereotactic MRI-guided online adaptive radiotherapy with elective fields in… DOI 10.1016/j.tipsro.2025.100354 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.